Inhibitory effect of IL-1β on galactose intestinal absorption in rabbits

Cellular Physiology and Biochemistry

Volumn 30, Issue 1, 2012, Pages 173-186

  Viñuales, Carmen ^a   Gascón, Sonia ^a,c   Barranquero, Cristina ^b,c   Osada, Jess ^b,c   Rodrguez Yoldi, Maria Jesús ^a,c,d  

^a Departamento de Farmacología y Fisiología   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d UNIVERSIDAD DE ZARAGOZA   (Spain)

Author keywords

Galactose; Gut; IL 1 ; Kinases; Rabbit

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GALACTOSE; IP 20; RECOMBINANT INTERLEUKIN 1BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; ASSAY; BODY TEMPERATURE; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL RABBIT; IN VIVO STUDY; INHIBITION KINETICS; INTESTINE ABSORPTION; INTESTINE BRUSH BORDER MEMBRANE; JEJUNUM MUCOSA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SUGAR TRANSPORT; WESTERN BLOTTING;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84863430519     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000339056     Document Type: Article

References (64)

1. Bachmann MF, Kopf M: Balancing protective immunity and immunopathology. Curr Opin Immunol 2002;14:413-419. (Pubitemid 34671242)
2. Powanda MC, Beisel WR: Metabolic effects of infection on protein and energy status. J Nutr 2003;133:322S-327S. (Pubitemid 36070628)
3. Riedemann NC, Guo RF, Hollmann T J , Gao H, Neff TA, Reuben JS, Speyer CL, Sarma JV, Wetsel RA, Zetoune FS, Ward PA: Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 2004;18:370-372.
4. Al-Sadi RM, Ma TY: I-lp causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007;178: 4641-4649. (Pubitemid 46492417)
5. Ligunsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686-689.
6. Dinarello CA: Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-550.
7. Dinarello CA: Interleukin-lp. Crit Care Med 2005;33:S460-S462.
8. Isaacs KL, Sartor RB, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mocosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-1595.
9. Reinecker HC, Steffen M, Doehn C, Petersen J , Pfluger I, Voss A, Raedler A: Proinflammatory cytokines in intestinal mucosa. Immunol Res 1991;10:247-248.
10. Bertolo C, Barrenetxe J , Barber A, Lostao MP: Cytokine effect on intestinal galactose absorption. J Physiol Biochem 2002;58: 61-62.
11. Kreydiyyeh SI, Haddad JJE, Garabedian B-S: Interleukin-1 beta inhibits the intestinal transport of [14C J 3-o-methylglucose in the rat. Life Sci 1998;63:1913-1919. (Pubitemid 28511604)
12. Chang EB, Musch MW, Mayer L: Interleukin 1 and 3 stimulate anion secretion in chicken intestine. Gastroenterology 1990;98:1518-1524. (Pubitemid 20158615)
13. Chiossone DC, Simon PL, Smith PL: Interleukin-1: effects on rabbit ileal mucosal ion transport in vitro. Eur J Pharmacol 1990;180:217-228. (Pubitemid 20170858)
14. Hardin J , Kroeker K, Chung B, Gall DG: Effect of proinflammatory interleukins on jejunal nutrient transport. Gut 2000;47:184-191. (Pubitemid 30489760)
15. Garcia-Barrios A, Guillen N, Osada J , Vazquez CM, Miguel-Carrasco JL, Rodriguez-Yoldi MJ: Nitric Oxide involved in the IL-lp-induced inhibition of fructose intestinal transport. J Cell Biochem 2010;111:1321-1329.
16. Amador P, Garcia-Herrera J , Marca MC, de la Osada J , Acin S, Navarro MA, Salvador MT, Lostao MP, Rodriguez-Yoldi MJ: Intestinal D-Galactose transport in an endotoxemia model in the rabbit. J Membr Biol 2007;215:125-133. (Pubitemid 47282679)
17. Amador P, Garcia-Herrera J, Marca MC, de la Osada J, Acin S, Navarro MA, Salvador MT, Lostao MP, Rodriguez-Yoldi MJ: Inhibitory effect of TNF-a on the intestinal absorption of Galactose. J Cell Biochem 2007;101:99-111. (Pubitemid 46652576)
18. Garcia-Herrera J, Marca MC, Brot-Laroche E, Guillen N, Acin S, Navarro MA, De la Osada J, Rodriguez-Yoldi MJ: Protein kinases, TNF-a, and proteasome contribute in the inhibition of fructose intestinal transport by sepsis in vivo. Am J Physiol-Gastrointest Liver Physiol 2008;294:G155-G164.
19. Abad B, Mesonero JE, Salvador MT, Garcia-Herrera J, Rodriguez-Yoldi MJ: The administration of lipopolysaccharide, in vivo, induces alteration in L-leucine intestinal absorption. Life Sci 2001;70:615-618.
20. Wright EM, Hirayama BA, Loo DF: Active sugar transport in health and disease. J Internal Med 2007;261:32-43. (Pubitemid 46046470)
21. Frobose H, Ronn SG, Heding PE, Mendoza H, Cohen P, Mandrup-Poulsen T, Billestrup N: Suppressor of cytokine signalling-3 inhibits Interleukin-1 signaling by targeting the TRAF-6/TAK1 Complex. Mol Endocrinol 2006;20:1587-1596. (Pubitemid 43967566)
22. Abad B, Mesonero JE, Salvador MT, Garcia-Herrera J, Rodriguez-Yoldi MJ: Cellular mechanism underlying LPS-induced inhibition of in vitro L-leucine transport across rabbit jejunum. J Endotox Res 2002;8:127-133. (Pubitemid 34546189)
23. Garcia-Herrera J, Abad B, Rodriguez-Yoldi MJ: Effect of lipopolysaccharide on D-fructose transport across rabbit jejunum. Inflamm Res 2003;52:177-184. (Pubitemid 36535267)
24. Amador P, Marca MC, Garcia-Herrera J, Lostao MP, Gillen N, de la Osada J, Rodriguez-Yoldi MJ: Lipopolysaccharide induces inhibition of Galactose intestinal transport in rabbits in vitro. Cell Physiol Biochem 2008;22:715-724.
25. McKay DM, Watson JL, Wang A, Caldwell J, Prescott D, Ceponis PMJ, Di Leo V, Lu J: Phosphatidylinositol 3-kinase is a critical mediator of interferon- A-induced increases in enteric epithelial permeability. J Pharmacol Exp Ther 2007;320:1013-1022. (Pubitemid 46294056)
26. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5595.
27. Bonizzi G, Karin M: The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288. (Pubitemid 38610351)
28. Rubinstein M, Dinarello CA, Oppenheim JJ, Hertzog P: Recent advances in cytokines, cytokine receptors and signal transduction. Cytokine Growth Factor Rev 1998;9:175-81. (Pubitemid 28376453)
29. Lewis SA, Berg JR, Kleine TJ: Modulation of epithelial permeability by extracellular macromolecules. Physiol Rev 1995;75:561-589.
30. Sears C, Kaper J: Enteric bacterial toxins: mechanisms of action and link-age to intestinal secretion. Microbiol Rev 1996;60:167-215. (Pubitemid 26087767)
31. McKay DM, Baird AW: Cytokine regulation of epithelial permeability and ion transport. Gut 1999; 44: 283-289. (Pubitemid 29119376)
32. Miller AJ, Hopkins SJ, Luheshi GN: Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Brit J Pharmacol 1997;120:1274-1279. (Pubitemid 27149677)
33. Eskan MA, Benakanakere MR, Rose BG, Zhang P, Zhao J, Stathopoulou P, Fujioka D, Kinane DF: Interleukin-lp modulates proinflammatory cytokine production in human epithelial cells. Infect Immun 2008;76:2080-2089. (Pubitemid 351656141)
34. Netea MG, Simon A, van de Veerdonk F, Kullberg B-J, Van der Meer JWM, Joosten LAB: IL-lp processing in host defense: beyond the inflammasomes. PloS Pathog 2010;6:1-9.
35. Abad B, Mesonero JE, Salvador MT, Garcia-Herrera J, Rodriguez-Yoldi MJ: Tumor necrosis factor-a mediates inhibitory effect of lipopolysaccharide on L-leucine intestinal uptake. Dig Dis Sci 2002;46:1316-1322. (Pubitemid 34606635)
36. Garcia-Herrera J, Navarro MA, Marca MC, De la Osada J, Rodriguez-Yoldi MJ: The effect of tumor necrosis factor-a on D-fructose intestinal transport in rabbits. Cytokine 2004;25:21-30. (Pubitemid 37543694)
37. O'Neill J, Greene C: Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects and plants. J Leukoc Biol 1998;63:650-657. (Pubitemid 28274824)
38. Bowie A, O'Neill LA J : The interleukin-1 receptor Toll-like receptor superfamily: signal generators for proinflammatory interleukins and microbial products. J Leukoc Biol 2000;67:508-514.
39. Chen CC, Chen J J , Chou CY: Protein Kinase C-alpha but not p44/42 Mitogen-Activated Protein Kinase, p38, or c-Jun NH2-Terminal Kinase Is Required for Intercellular Adhesion Molecule-1 Expression Mediated by Interleukin-lp: Involvement of Sequential Activation of Tyrosine Kinase, Nuclear Factor-kB-Inducing Kinase, and IkB Kinase 2. Mol Pharmacol 2000;58:1479-1489.
40. Kyriakis JM, Avruch J : Mammalian mitogen-activate protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869. (Pubitemid 32267078)
41. Hambleton J , Weinstein SL, Lem L, De Franco AL: Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Nat Acad Sci USA 1996;93:2774-2778.
42. van den Blink B, Branger J , Weijer S, van Deventer SJH, van der Poll T, Peppelenbosch MP: Human endotoxemia activates p38 MAP kinase and p42/44 MAP kinase but not c-Jun-N-terminal kinase. Mol Med 2001;7:755-760. (Pubitemid 34175296)
43. Ikeda M, Gunji Y, Yamasaki S, Takeda Y: Shiga toxin activates p38 MAP kinase through cellular Ca2* increase in vero cells. FEBS Lett 2000;485:94-98.
44. van den Blink B, Juffermans NP, Hove TT, Schultz M J , van Deventer SJH, van der Poll T, Peppelenbosch AP: p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J Immunol 2001;166:582-587. (Pubitemid 32038480)
45. Hommes D, Van den Blink B, Plasse T, Bartelsman J , Xu C, Macpherson B, Tytgat G, Peppelenbosch M, van Deventer S: Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease. Gastroenterology 2002;122:7-14. (Pubitemid 34049188)
46. Stein RC: Prospects for phosphoinositide 3-kinase inhibition as a cancer treatment. Endocr Relat Cancer 2001;8:237-248. (Pubitemid 32947646)
47. Wright EM, Hirsch JR, Loo DDF, Zampighi GA: Regulation of NaVglucose cotransporters. J Exp Biol 1997;200:287-293.
48. Delezay 0, Baghdiguian S, Fantini J : The development of Na*-dependent glucose transport during differentiation of an intestinal epithelial cell clone is regulated by PKC. J Biol Chem 1995;279:12536-12541.
49. Vayro S, Silverman M: PKC regulates turnover rate of rabbit intestinal NaVglucose transporter expressed in COS-7 cells. Am J Physiol Cell Physiol 1999;276:C1053-C1060. (Pubitemid 29244658)
50. Hirsch JR, Loo DDF, Wright EM: Regulation of NaVglucose cotransporter expression by protein kinases in Xenopuslaevis oocytes. J Biol Chem 1996;271:14740-14746. (Pubitemid 26194952)
51. Heinke B, Ribeiro R, Diener M: Involvement of calmodulin and protein kinase C in the regulation of K* transport by carbachol across the rat distal colon. Eur J Pharmacol 1999;377:75-80. (Pubitemid 29322761)
52. Helliwell PA, Richardson M, Affleck J , Kellett GL: Regulation of GLUT5, GLUT2 and intestinal brush-border fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and phosphatidylinositol 3-kinase intracellular signalling pathways. Implications for adaptation to diabetes. Biochem J 2000;350:163-169.
53. Pan M, Steven BR: Protein kinase C-dependent regulation of L-arginine transport activity in Caco-2 intestinal cells. Biochem Biophys Acta 1995;1239:27-32.
54. Pan M, Stevens BR: Differentiation and protein kinase C dependent regulation of alanine transport via system B. J Biol Chem 1995;270:3582-3587.
55. Vayro S, Silverman M: PKC regulates turnover rate of rabbit intestinal Na-i-glucose transporter expressed in COS-7 cells. Am J Physiol Cell Physiol 1999;276:C1053-C1060. (Pubitemid 29244658)
56. Helliwell PA, Rumsby MG, Kellett GL: Intestinal sugar absorption is regulated by phosphorylation and turnover of protein kinase C pll mediated by phosphatidylinositol 3-kinase-and mammalian target of rapamycin-dependent pathways. J Biol Chem 2003;278:28644-28650. (Pubitemid 36935770)
57. Millar GA, Hardin JA, Johnson LR, Gall DG: The role of PI 3-kinase in EGF-stimulated jejunal glucose transport. Can J Phys Pharm 2002;80:77-84. (Pubitemid 34194289)
58. Cui X-L, Schlesier AM, Fisher EL, Cerqueira C, Ferraris RP: Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signalling pathway. Am J Physiol Gastrointest Liver Physiol 2005;288:G1310-G1320. (Pubitemid 40741086)
59. Field M: Ion transport in rabbit ileal mucosa. II. Effects of cyclic 3', 5'-AMP Am J Physiol 1971; 221: 992-997.
60. Gouyon F, Onesto C, Dalet V, Pages G, Leturque A, Brot-Laroche E: Fructose modulates GLUT5 mRNA stability in differentiated Caco-2 cells: role of cAMP-signalling pathway and PABP (polyadenyllated-binding protein)-interacting protein (paip)2. Biochem J 2003;375:167-174. (Pubitemid 37255392)
61. Mesonero J E, Matosin M, Cambier D, Rodriguez-Yoldi M J , Brot-Laroche E: Sugar-dependent expresion of the fructose transporter GLUT5 in Caco-2 cells. Biochem J 1995;312:757-762. (Pubitemid 26005984)
62. Shikhman AR, Brinson DC, Lotz MK: Distinct pathways regulate facilitated glucose transport in human articular chondrocytes during anabolic and catabolic responses. Am J Physiol Endocrinol Metab 2004;286: E980-E985. (Pubitemid 38668822)
63. Mercurio F, Manning AM: Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 1999;11:226-232.
64. Haddad J J , Lauterbach R, Saade NE, Safieh-Garabedian B, Land SC: Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-lbetal93-195 receptor antagonism in the alveolar epithelium. Biochem J 2001;355:29-38. (Pubitemid 32318324)